A note before anything else, because it's the thing most healthtech founders get backwards: compliance is not security, and security is not compliance. Compliance is a checklist a regulator agrees you've met. Security is whether an attacker actually gets in. You can be perfectly HIPAA-compliant on paper and still leak patient records; you can be genuinely secure and still fail an audit on documentation. Real clinical-grade software needs both the controls and the evidence, because in healthcare the demo and the audit are the same exam.
HIPAA isn't a badge you buy. It's a set of safeguards that have to be designed into the architecture. For an early-stage product, the ones that matter most:
Get these into the foundation and the 1% you actually want to demo (your AI feature, your scheduling flow, your patient portal) becomes safe to build on top. Skip them and the 1% never survives contact with a real clinic.
Three acronyms come up in every healthtech build, so here's the plain version:
The reason this matters for an MVP: interoperability and the BAA chain are architectural decisions. Decide them late and you're rebuilding, not adding.
We build the foundation before the clever part. For a healthtech MVP that means: HIPAA-aligned environment first, then clean clinical data via FHIR, then human-in-the-loop AI, then the audit-ready hardening that lets you hand a security questionnaire back answered line by line.
We're deliberate about what we claim. We say "HIPAA-compliant by design, BAA-backed", and we don't claim a certificate we don't hold, because regulated buyers verify and one fabricated claim caught in diligence costs you the deal. In a domain this strict, the credible team is the one that tells you exactly where the line is.
That discipline matters most for clinical AI. A repurposed consumer chatbot pointed at patient data does not qualify as HIPAA-compliant, however good the model is. AI on clinical data has to run inside a verified framework (PHI masking, audit logs, human review on anything affecting care) with accuracy measured and reported, never a black box. The winners in clinical AI aren't the ones with the flashiest model; they're the ones whose AI can pass the audit.
GenRx is a secure biomedical-prediction architecture that reads messy clinical PDFs and predicts pharmacokinetic metrics, built on a HIPAA-aligned AWS foundation before a single prediction ran. It's rated 5.0 on Clutch: "Deep expertise in AI, ML and security, a commercially viable architecture." (Chris Howell, Founder, GenRx.)
We've also built a multi-tenant EHR running across four US clinics at around 300 patients a day, where the boring foundation, not the flashy feature, is what made it dependable. The pattern is always the same: the architecture that makes the model safe and credible is the product.
We price by phase, from $10K/month, fixed per phase, so you have a known number before you start. A credible pitch demo in 10 days; an investor-ready MVP in 6 weeks, on a HIPAA-aligned foundation rather than a throwaway prototype. You own the IP, source code and GitHub repository from day one. Healthcare adds the compliance premium described above, but building it in is the cheaper path every time. For the general picture, see our MVP development cost breakdown.
We build HIPAA-compliant-by-design, BAA-backed software: the architecture, controls and audit-ready hardening required. HIPAA has no official certification, so beware anyone claiming to be "HIPAA certified." We build to the standard and answer your security questionnaire line by line.
Bring us your product idea and we'll map the compliance surface, the interoperability you'll need, and where the landmines are, in a free 30-minute review. If we're not the right team, we'll point you to someone who is.